These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12207101

  • 1. Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia.
    Drüeke TB, Massy ZA.
    Blood Purif; 2002; 20(5):494-7. PubMed ID: 12207101
    [Abstract] [Full Text] [Related]

  • 2. [Functional disorder of the parathyroid gland and vascular calcification in hemodialysis patients].
    Nakanishi S, Fukagawa M.
    Clin Calcium; 2005 Jul; 15(7):119-23. PubMed ID: 15995307
    [Abstract] [Full Text] [Related]

  • 3. [Control of calcium and phosphate metabolism and prevention of vascular calcifications in uremic patients].
    Malberti F, Ravani P.
    G Ital Nefrol; 2005 Jul; 22 Suppl 31():S47-52. PubMed ID: 15786402
    [Abstract] [Full Text] [Related]

  • 4. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E.
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [Abstract] [Full Text] [Related]

  • 5. Association between advanced oxidation protein products (AOPP) and vascular calcification in uremic patients.
    Lin L, Zhao GJ, Qin LL.
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4147-4152. PubMed ID: 29028083
    [Abstract] [Full Text] [Related]

  • 6. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V.
    Verh K Acad Geneeskd Belg; 2008 Sep; 70(4):285-303. PubMed ID: 19166100
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Cinacalcet suppresses calcification of the aorta and heart in uremic rats.
    Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, Wakita S, Wada M.
    Kidney Int; 2008 Nov; 74(10):1270-7. PubMed ID: 18813289
    [Abstract] [Full Text] [Related]

  • 9. Vascular calcifications in uremia: old concepts and new insights.
    Derici U, El Nahas AM.
    Semin Dial; 2006 Nov; 19(1):60-8. PubMed ID: 16423183
    [Abstract] [Full Text] [Related]

  • 10. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
    Caudrillier A, Mentaverri R, Brazier M, Kamel S, Massy ZA.
    J Nephrol; 2010 Nov; 23(1):17-22. PubMed ID: 20091482
    [Abstract] [Full Text] [Related]

  • 11. Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease.
    Coen G.
    Kidney Int; 2008 Nov; 74(10):1229-31. PubMed ID: 18974757
    [Abstract] [Full Text] [Related]

  • 12. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
    Tamagaki K, Yuan Q, Ohkawa H, Imazeki I, Moriguchi Y, Imai N, Sasaki S, Takeda K, Fukagawa M.
    Nephrol Dial Transplant; 2006 Mar; 21(3):651-9. PubMed ID: 16311258
    [Abstract] [Full Text] [Related]

  • 13. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.
    Lim K, Kalim S.
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):427-436. PubMed ID: 31831121
    [Abstract] [Full Text] [Related]

  • 14. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T.
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [Abstract] [Full Text] [Related]

  • 15. Treatment of cardiovascular calcification in uremia.
    Mazzaferro S, Pasquali M, Cozzolino M.
    Curr Vasc Pharmacol; 2011 Nov; 9(6):741-9. PubMed ID: 21824104
    [Abstract] [Full Text] [Related]

  • 16. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M, Gallieni M, Brancaccio D.
    Semin Nephrol; 2006 Jan; 26(1):33-7. PubMed ID: 16412823
    [Abstract] [Full Text] [Related]

  • 17. Vascular biology in uremia: insights into novel mechanisms of vascular injury.
    Al Aly Z, Edwards JC.
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):310-8. PubMed ID: 15241745
    [Abstract] [Full Text] [Related]

  • 18. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
    Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW.
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
    [Abstract] [Full Text] [Related]

  • 19. Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin.
    Ketteler M, Vermeer C, Wanner C, Westenfeld R, Jahnen-Dechent W, Floege J.
    Blood Purif; 2002 Aug; 20(5):473-6. PubMed ID: 12207096
    [Abstract] [Full Text] [Related]

  • 20. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R.
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.